Induction of Caspase-3 Dependent Apoptosis in Human Ovarian Cancer SK-OV-3 Cells by Genistein

  • Choi, Eun-Jeong (Plant Resources Research Institute, Duksung Women's University) ;
  • Kim, Tae-Hee (Plant Resources Research Institute, Duksung Women's University) ;
  • Kim, Gun-Hee (Plant Resources Research Institute, Duksung Women's University) ;
  • Chee, Kew-Mahn (Department of Biotechnology and Life Sciences, Korea University)
  • Published : 2008.02.29

Abstract

The present study was designed to determine how the phytochemical genistein activates caspase-3 to cause cell cycle arrest and apoptosis. When human ovarian cancer SK-OV-3 cells were treated with $200\;{\mu}M$ genistein for 24 hr, cell growth decreased significantly (p<0.05). Conversely, genistein treatment significantly increased cytotoxicity (measured as lactate dehydrogenase release) under the same conditions (p<0.05). To elucidate the mechanism behind the induction of apoptosis by genistein, we studied the cell cycle and caspase-3 activation. When cells were treated with genistein, the population of cells in sub-G1 phase increased by 44.2% compared to untreated cells. Genistein caused decrease in precursor caspase-3, increase in cleaved caspase-3 and a significant increase in caspase-3 activity (p<0.05). Therefore, genistein may induce apoptosis via caspase-3 activation. However, high-dose genistein treatment must be viewed with caution because of its potential cytotoxicity.

Keywords

References

  1. Liggins J, Bluck LJ, Runswick S, Atkinson C, Coward WA, Bingham SA. Daidzein and genistein contents of vegetables. Brit. J. Nutr. 4: 717-725 (2000)
  2. Kim M-J, Koh E, Surh J, Lee Kim Y-K, Kwon H. Distribution of isoflavones and coumestrol in legumes and their products consumed in Korea. Food Sci. Biotechnol. 12: 278-284 (2003)
  3. Ziegler RG, Hoover RN, Pike MC, Hildesheim A, Nomura AM, West DW, Wu-Williams AH, Kolonel LN, Horn-Ross PL, Rosenthal JF. Migration patterns and breast cancer risk in Asian-American women. J. Natl. Cancer I. 85: 1819-1827 (1993) https://doi.org/10.1093/jnci/85.22.1819
  4. Wu AH, Ziegler RG, Horn-Ross PL, Nomura AM, West DW, Kolonel LN, Rosenthal JF, Hoover RN, Pike MC. Tofu and risk of breast cancer in Asian-Americans. Cancer Epidem. Biomar. 5: 901- 906 (1996)
  5. Akiyama T, Ishida J, Nakagawa S, Ogawara H, Watanabe S, Itoh N, Shibuya M, Fukami Y. Genistein, a specific inhibitor of tyrosinespecific protein kinases. J. Biol. Chem. 262: 5592-5595 (1987)
  6. Ullrich A, Schlessinger J. Signal transduction by receptors with tyrosine kinase activity. Cell 61: 203-212 (1990) https://doi.org/10.1016/0092-8674(90)90801-K
  7. Kyle E, Neckers L, Takimoto C, Curt G, Bergan R. Genistein-induced apoptosis of prostate cancer cells is preceded by a specific decrease in focal adhesion kinase activity. Mol. Pharmacol. 51: 193-200 (1997) https://doi.org/10.1124/mol.51.2.193
  8. Choi J-M, Ryu H-J, Chung J-H, Park J-C, Hwang J-K, Shin D-B, Lee S-K, Ryang R. Antioxidant property of genistein: Inhibitory effect on HOCl induced protein degradation, DNA cleavage, and cell death. Food Sci. Biotechnol. 14: 399-404 (2005)
  9. Lamartiniere CA. Protection against breast cancer with genistein: A component of soy. Am. J. Clin. Nutr. 71: 1705S-1709S (2000) https://doi.org/10.1093/ajcn/71.6.1705S
  10. Kim JH, Lim HA, Lee JS, Sung M-K, Kim YK, Yu RN, Kim J-S. Effect of low doses of genistein and equol on protein expression profile in MCF-7 Cells. Food Sci. Biotechnol. 14: 854-859 (2005)
  11. Salti GI, Grewal S, Mehta RR, Das Gupta TK, Boddie Jr AW, Constantinou AI. Genistein induces apoptosis and topoisomerase IImediated DNA breakage in colon cancer cells. Eur. J. Cancer 36: 796-802 (2000) https://doi.org/10.1016/S0959-8049(00)00017-4
  12. Yoon HS, Moon SC, Kim ND, Park BS, Jeong MH, Yoo YH. Genistein induces apoptosis of RPE-J cells by opening mitochondrial PTP. Biochem. Bioph. Res. Co. 276: 151-156 (2000) https://doi.org/10.1006/bbrc.2000.3445
  13. Kumi-Diaka J, Butler A. Caspase-3 protease activation during the process of genistein-induced apoptosis in TM4 testicular cells. Biol. Cell 92: 115-124 (2000) https://doi.org/10.1016/S0248-4900(00)89019-X
  14. Hattori T, Hayashi H, Chiba T, Onozaki K. Activation of two distinct anti-proliferative pathways, apoptosis, and p38 MAP kinasedependent cell cycle arrest, by tumor necrosis factor in human melanoma cell line A375. Eur. Cytokine Netw. 12: 244-252 (2001)
  15. Srivastava SK, Singh SV. Cell cycle arrest, apoptosis induction and inhibition of nuclear factor kappa B activation in anti-proliferative activity of benzyl isothiocyanate against human pancreatic cancer cells. Carcinogenesis 25: 1701-1709 (2004) https://doi.org/10.1093/carcin/bgh179
  16. Kuo PL, Hsu YL, Kuo YC, Chang CH, Lin CC. The anti-proliferative inhibition of ellipticine in human breast mda-mb-231 cancer cells is through cell cycle arrest and apoptosis induction. Anticancer Drug 16: 789-795 (2005) https://doi.org/10.1097/01.cad.0000171768.36317.93
  17. Shin J-I, Lee M-S, Park O-J. Effects of soy-isoflavonoid on molecular markers related to apoptosis in mature and ovariectomized female rats, and mammalian tumor cell lines. Food Sci. Biotechnol. 14: 709- 714 (2005)
  18. Choi EJ, Lee BH. Evidence for genistein mediated cytotoxicity and apoptosis in rat brain. Life Sci. 75: 499-509 (2004)
  19. Sun S-Y, Hail N, Lotan R. Apoptosis as a novel target for cancer chemoprevention. J. Natl. Cancer I. 96: 2662-2672 (2004)
  20. Zhang Z, Li M, Rayburn ER, Hill DL, Zhang R, Wang H. Oncogenes as novel targets for cancer therapy (part IV): Regulators of the cell cycle and apoptosis. Am. J. Pharmacogenomic 5: 397- 407 (2005) https://doi.org/10.2165/00129785-200505060-00006
  21. Fesik SW. Promoting apoptosis as a strategy for cancer drug discovery. Nat. Rev. Cancer 5: 876-885 (2005) https://doi.org/10.1038/nrc1736